Chronopharmacologic considerations when treating the patient with hypertension: A review

Journal of Clinical Pharmacology

Volumn 36, Issue 9, 1996, Pages 771-782

  Straka, Robert J ^a   Benson, Steven R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; AROTINOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CELIPROLOL; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDORAMIN; ISRADIPINE; LABETALOL; LACIDIPINE; LISINOPRIL; METOPROLOL; NIFEDIPINE; NILVADIPINE; NITRENDIPINE; PINDOLOL; PRAZOSIN; QUINAPRIL; SOTALOL; UNINDEXED DRUG; VERAPAMIL;

AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; HYPERTENSION; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0029740021     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04250.x     Document Type: Review

References (47)

1. Lanuza D, Dunbar S: Circadian rhythms: implications for cardiovascular nursing and drug therapy. J Cardiovasc Nursing 1993;8:63-79.
2. Pepine C: Therapeutic implications of circadian variations in myocardial ischemia and related physiologic functions. Am J Hypertension 1991;4(Suppl):442S-448S.
3. Materson B, Preston R: Antihypertensive drug therapy does not perturb the circadian blood pressure pattern. J Clin Pharmacol 1992;32:627-629.
4. Kraft M, Martin R: Chronobiology and chronotherapy in medicine. Dis Mon 1995;41:501-575.
5. Rocco M, Barry J, Campbell S, et al: Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400.
6. Willich S, Levy D, Rocco M, et al: Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study Population. Am J Cardiol 1987;60:801-806.
7. Panza J, Epstein S, Quyyumi A: Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. New Engl J Med 1991;325:986-990.
8. Pescini A, Simoni A: Clinical utility and prognostic value of ambulatory blood pressure monitoring. Biomed Pharmacother 1991;45:327-332.
9. Gould B, Hornung R, Mann S: Slow channel inhibitors verapamil and nifedipine in the management of hypertension. J Cardiovasc Pharmacol 1982;4(suppl 3):S369-S373.
10. Raftery E: Circadian variation in blood pressure: considerations for therapy. Postgrad Med J 1991;67(suppl 5):S9-S14.
11. Mele D, Manfredini R, Amadei G, et al: Circadian rhythm of blood pressure and calcium entry blockade: a chronobiologic study with nitrendipine in essential hypertension. J Cardiovasc Pharmacol 1991;18(suppl 1):S51-S54.
12. Mele D, Manfredini R, Amadei G, et al: Acute ands chronic nitrendipine administration in essential hypertension: a chronobiologic study. J Cardiovasc Pharmacol 1992;19(suppl 2):S49-S52.
13. Yasky J, Ferrario C: Nocturnal hypotension and ACE inhibitors. J Hum Hypertension 1993;7:299-304.
14. Pannarale G, Puddu P, Campbell S, et al: Effects of slow-release verapamil and nitrendipine on office and 24-hour ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1992;19(suppl 2):S53-S56.
15. Cihak R, Widimsky J, Lefflerova K, et al: Effect of isradipine on 24-hour blood pressure profile demonstrated by repeated monitoring. Am J Hypertension 1991;4:158S-160S.
16. Viskoper J, Laszt A, Faraggi D: Twenty-four-hour blood pressure control with isradipine in mild essential hypertension. Am J Hypertension 1991;4:161S-162S.
17. Diemont W, Stegeman C, Beekman J, et al: Low-dose isradipine once daily effectively controls 24-hour blood pressure in essential hypertension. Am J Hypertension 1991;4:163S-167S.
18. Fogari R, Malacco E, Tettamanti F, et al: Evening vs morning isradipine sustained release in essential hypertension: a double blind study with 24 hour ambulatory monitoring. Br J Clin Pharmacol 1993;35:51-54.
19. Tsuchihashi T, Tsukashima A, Matsumura K, et al: Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist nilvadipine. Eur J Clinical Pharmacol 1991;41:255-257.
20. Raftery E: Lacidipine and circadian variation in blood pressure: considerations for therapy. J Cardiovasc Pharmacol 1991;17(suppl 4):S20-S26.
21. White B, Anders R, MacIntyre J, et al: Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol 1995;76:375-380.
22. Meijer J, Ardesch H, van Rooijen J, et al: Low dose captopril twice daily lowers blood pressure without disturbance of the normal circadian rhythm. Postgrad Med J 1986;62(suppl 1):101-105.
23. Sirgo M, Mills R, DeQuattro V: Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. Arch Intern Med 1988;148:2547-2552.
24. Middeke M, Kluglich M, Holzgreve H: Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing. Chronobiol Int 1991;8:506-510.
25. Jones R, Hornung R, Cashman P, et al: Effect of enalapril at rest, during tilt, static and dynamic exercise in systemic hypertension. Am J Cardiol 1985;55:1534-1538.
26. Whelton A, Miller W, Dunne B Jr, et al: Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures. J Clin Pharmacol 1990;30:1074-1080.
27. Whelton A, Dunne B Jr, Glazer N, et al: Twenty-four hour blood pressure effect of once daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension. J Hum Hypertension 1992;6:325-331.
28. Hwang Y, Yen H: Efficacy of once-daily lisinopril monotherapy in systemic hypertension. Clin Cardiol 1993;16:129-132.
29. Palatini P, Racioppa A, Raule G, et al: Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992; 52: 378-383.
30. Witte K, Weisser K, Neubeck M, et al: Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 1993;54:177-186.
31. Miyakawa T, Minamisawa K, Yamada Y, et al: A study of the effects of delapril, a new angiotensin converting enzyme inhibitor, on the diurnal variation of arterial pressure in patients with essential hypertension using indirect and direct arterial pressure monitoring methods. Am J Hypertension 1991;4:29S-37S.
32. Millar Craig M, Kenny D, Mann S, et al: Effect of once-daily atenolol on ambulatory blood pressure. Br Med Journal 1979;1: 237-238.
33. Floras J, Fox P, Hassan M, et al: Assessment of the antihypertensive effect of atenolol with 24 hour ambulatory monitoring of blood pressure. Clin Sci 1979;57:387S-389S.
34. Neutel J, Schnaper H, Cheung D, et al: Antihypertensive effects of B-blockers administered once daily: 24-hour measurements. Am Heart J 1990;120:166-171.
35. Mann S, Millar Craig M, Balasubramanian V, et al: Once daily β-adrenergic blockade in hypertension: an ambulatory assessment. Br J Clin Pharmacol 1981;12:223-228.
36. Mann S, Millar Craig M, Altman D, et al: The effects of metoprolol on ambulatory blood pressure. Clin Sci 1979;57:375S-377S.
37. Balasubramanian V, Mann S, Raftery E, et al: Effects of labetalol on continuous ambulatory blood pressure. Br J Clin Pharmacol 1979;8:119S-123S.
38. Mancia G, Pomidossi G, Parati G, et al: Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period. Br J Clin Pharmacol 1982;13:27S-35S.
39. Heber M, Brigden G, Caruana M, et al: Carvedilol for systemic hypertension. Am J Cardiol 1987;59:400-405.
40. Raftery E: Carvedilol in hypertension. Cardiology 1993; 82(suppl 3):40-44.
41. Kuwajima I, Suzuki Y, Otsuka K, et al: Effects of alpha, beta-blocker, arotinolol chloride, on 24 hour blood pressure: difference between elderly and younger patients. J Clin Pharm Ther 1993;18: 275-280.
42. Brigden G, Heber M, Caruana M, et al: The efficacy of celiprolol in hypertension: twenty-four-hour blood pressure profiles and left ventricular function. J Hypertension 1987;5(suppl 5):S539-S541.
43. Gould B, Hornung R, Kieso H, et al: Prazosin alone and combined with a beta-adrenoreceptor blocker in treatment of hypertension. J Clin Pharmacol 1983;5(suppl 1):678-684.
44. Gould B, Raftery E: Twenty-four-hour blood pressure control: an intraarterial review. Chronobiol Int 1991;8:495-505.
45. Smyth P, Pringle S, Jackson G, et al: 24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo. Eur J Clin Pharmacol 1988;34:613-618.
46. Boelke T, Achhammer I, Meyer-Sabellek W, et al: Tagesund Nachrthythmik ambulanter 24-h Blutdruckwerte von alteren essentiellen Hypertonikern bei Therapie mit verschiedenen Antihypertonika. Hochdruck 1990;10:40.
47. Baumgart P: Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther 1993;7:63-68.